The INNOVA project aims to create an advanced multidisciplinary diagnostic platform to support the Italian healthcare system and translational research. In this context, WP7, coordinated by the Pascale Institute and the focus of this study protocol, is responsible for developing a national platform for the multi-omic profiling of cancer patients eligible for precision medicine treatments, with the goal of supporting clinical decision-making.
Consent to participate in the study
Age >18 years
Performance status (PS) 0-1
Availability of biological samples for multi-omic profiling
Previous line of immunotherapy or targeted therapy
Previous radiotherapy at the sites of the most recent diagnostic biopsy
Most recent diagnostic biopsy performed >24 months before enrollment
Absence of measurable lesions